Vietnam Investment Review on MSN

GenScript and Mimulus partner on DNA data storage

PISCATAWAY, N.J. and LOS ANGELES, April 9, 2026 /PRNewswire/ -- GenScript Biotech Corporation, the world's leading provider of CMOS-based DNA synthesis technologies, and Mimulus Corp, the pioneer in ...
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Revvity, Inc. announced that its Revvity Signals Software business is launching Signals BioDesignTM, a cloud-native molecular cloning solution that streamlines biologics research workflows. Built for ...
Satellos Bioscience Inc.  (" Satellos " or the " Company "), a clinical-stage biotechnology company developing life-improving medicines to treat degenerative muscle diseases, today announced that it ...
The collaboration pairs Mimulus's molecular architecture with GenScript's massive synthesis scale to liberate critical grid power for AI compute and launch the "Forever Archive" for enterprise data ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Looking for a biopharma job in Texas? Check out the BioSpace list of 10 companies hiring life sciences professionals like you ...
With an approved treatment in commercial stages and new drug candidates generating clinical trial results, this biotech has ...
Innovation often pays off, and this biotech could cement its innovative capabilities in the next few years.
According to Mordor Intelligence, the synthetic biology market size was valued at USD 19.75 billion in 2025 and is projected to grow to USD 23.53 billion in 2026, reaching an estimated USD 56.48 ...
Life Biosciences Inc. closed on an $80 million financing that will fund the anti-aging company’s operations into the second ...
The synthetic biology market is being shaped by the growing use of engineered organisms in drug development, vaccine production, and gene therapies. The ability to manipulate DNA and create customized ...